Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,932 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Analysis of En Bloc Resection for Advanced Temporal Bone Squamous Cell Carcinoma.
Komune N, Kuga D, Matsuo S, Miyazaki M, Noda T, Sato K, Hongo T, Koike K, Uchi R, Kogo R, Tsuchihashi NA, Masuda S, Nakagawa T. Komune N, et al. Among authors: masuda s. J Neurol Surg B Skull Base. 2021 Feb 12;83(Suppl 2):e40-e48. doi: 10.1055/s-0041-1722930. eCollection 2022 Jun. J Neurol Surg B Skull Base. 2021. PMID: 35832936 Free PMC article.
Management of Residual Hearing with Cartilage Conduction Hearing Aid after Lateral Temporal Bone Resection: Our Institutional Experience.
Komune N, Higashino Y, Ishikawa K, Tabuki T, Masuda S, Koike K, Hongo T, Sato K, Uchi R, Miyazaki M, Shimamoto R, Tsuchihashi NA, Kogo R, Noda T, Matsumoto N, Nakagawa T. Komune N, et al. Among authors: masuda s. Audiol Res. 2021 Jun 9;11(2):263-274. doi: 10.3390/audiolres11020024. Audiol Res. 2021. PMID: 34207894 Free PMC article.
Inhibition of PTPN3 Expressed in Activated Lymphocytes Enhances the Antitumor Effects of Anti-PD-1 Therapy in Head and Neck Cancer, Especially in Hypoxic Environments.
Masuda S, Onishi H, Iwamoto N, Imaizumi A, Koga S, Nagao S, Sakanashi K, Itoyama S, Fujimura A, Komune N, Kogo R, Umebayashi M, Morisaki T, Nakagawa T. Masuda S, et al. J Immunother. 2024 Apr 1;47(3):89-97. doi: 10.1097/CJI.0000000000000503. Epub 2024 Feb 1. J Immunother. 2024. PMID: 38297883
Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma.
Ichimiya S, Fujimura A, Masuda M, Masuda S, Yasumatsu R, Umebayashi M, Tanaka H, Koya N, Nakagawa S, Yew PY, Yoshimura S, Onishi H, Nakamura M, Nakamura Y, Morisaki T. Ichimiya S, et al. Among authors: masuda m, masuda s. Immunol Invest. 2022 Jul;51(5):1498-1514. doi: 10.1080/08820139.2021.1973491. Epub 2021 Sep 5. Immunol Invest. 2022. PMID: 34486463
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor.
Koga S, Onishi H, Masuda S, Fujimura A, Ichimiya S, Nakayama K, Imaizumi A, Nishiyama K, Kojima M, Miyoshi K, Nakamura K, Umebayashi M, Morisaki T, Nakamura M. Koga S, et al. Among authors: masuda s. Transl Oncol. 2021 Sep;14(9):101152. doi: 10.1016/j.tranon.2021.101152. Epub 2021 Jun 13. Transl Oncol. 2021. PMID: 34134073 Free PMC article.
1,932 results